Skip to content

Clinical trials

Phase 3 Pain trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pain Phase: Phase 3 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20112
20121
20131
20151
20171
20181
20191
20201
20214
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong2
Jiangsu HengRui Medicine Co., Ltd.2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
Shijiazhuang Yiling Pharmaceutical Co. Ltd2
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
GlaxoSmithKline1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Lei Jiang1
Mundipharma (China) Pharmaceutical Co. Ltd1
Shanghai Cancer Hospital, China1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pain17
Thoracic Neoplasms2
Ankle Injuries1
Carcinoma, Bronchogenic1
Carcinoma, Non-Small-Cell Lung1
Diabetic Neuropathies1
Lung Diseases1
Lung Neoplasms1
Mediastinal Neoplasms1
Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.